Evidence map›Paper›PMID 39309323›Full record

ReviewAmerican journal of lifestyle medicine

Strengthening Neuroplasticity in Substance Use Recovery Through Lifestyle Intervention.

Steven G Sugden, Gia Merlo, Sam Manger

Abstract readReview
In one paragraph

Review in American journal of lifestyle medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Great Progress, Enormous Challenges.American journal of lifestyle medicine
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Steven G SugdenHuntsman Mental Health Institute, University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT, USA (SS).ORCID https://orcid.org/0000-0002-2255-9804
Gia MerloGrossman School of Medicine, New York University, Garwood, NJ, USA (GM).ORCID https://orcid.org/0000-0002-7209-5403
Sam MangerAcademic Lead, Lifestyle Medicine, James Cook University, Australia.ORCID https://orcid.org/0000-0001-7959-3811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of substance use and behavioral addictions continues to increase throughout the world. The Global Burden of Disease Study shows a growing impact in disability-adjusted life years due to substance use. Substance use impacts families, communities, health care, and legal systems; yet, the vast majority of individuals with substance use disorders do not seek treatment. Within the United States, new legislation has attempted to increase the availability of buprenorphine, but the impact of substance use continues. Although medications and group support therapy have been the mainstay of treatment for substance use, lifestyle medicine offers a valuable adjunct therapy that may help strengthen substance use recovery through healthy neuroplastic changes.

Indexed as

dopamine reward pathwaylifestyle interventionsneuroinflammationpillars of lifestyle medicineserotoninsubstance use disorders

Identifiers

PMID39309323
PMCPMC11412380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.